|
NL6815872A
(enExample)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(enExample)
*
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
JPS6130554A
(ja)
|
1984-07-23 |
1986-02-12 |
Ono Pharmaceut Co Ltd |
プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
DE3608088C2
(de)
|
1986-03-07 |
1995-11-16 |
Schering Ag |
Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
|
|
JP2716986B2
(ja)
|
1987-07-17 |
1998-02-18 |
シエーリング アクチエンゲゼルシヤフト |
９‐ハロゲン‐（ｚ）‐プロスタグランジン誘導体、その製法及び薬剤としてのその使用
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US5631401A
(en)
|
1994-02-09 |
1997-05-20 |
Abbott Laboratories |
Inhibitors of protein farnesyltransferase and squalene synthase
|
|
US5585492A
(en)
|
1994-10-11 |
1996-12-17 |
G. D. Searle & Co. |
LTA4 Hydrolase inhibitors
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
AU1952597A
(en)
|
1996-02-13 |
1997-09-02 |
G.D. Searle & Co. |
Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
|
|
US5952349A
(en)
*
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
US6184235B1
(en)
|
1996-08-14 |
2001-02-06 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as MCP-1 antagonists
|
|
NO317155B1
(no)
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
ATE237587T1
(de)
|
1997-02-10 |
2003-05-15 |
Ono Pharmaceutical Co |
11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
|
|
DE19743435A1
(de)
*
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
WO1999033794A1
(en)
|
1997-12-25 |
1999-07-08 |
Ono Pharmaceutical Co., Ltd. |
φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES
|
|
US6380203B1
(en)
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
JP4087938B2
(ja)
|
1998-02-04 |
2008-05-21 |
高砂香料工業株式会社 |
ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物
|
|
US6054590A
(en)
|
1998-03-25 |
2000-04-25 |
Bristol-Myers Squibb Company |
Imidazolone anorectic agents: II. phenyl derivatives
|
|
US6235780B1
(en)
|
1998-07-21 |
2001-05-22 |
Ono Pharmaceutical Co., Ltd. |
ω-cycloalkyl-prostaglandin E1 derivatives
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
AU2001234420A1
(en)
|
2000-02-03 |
2001-08-14 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
US6875483B2
(en)
|
2000-07-06 |
2005-04-05 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and alignment promoter
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
DE60229114D1
(en)
|
2001-03-02 |
2008-11-13 |
Axys Pharm Inc |
Cathepsincystein-proteasehemmer
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
IL160845A0
(en)
|
2001-09-14 |
2004-08-31 |
Tularik Inc |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
CN1688307A
(zh)
|
2002-10-04 |
2005-10-26 |
Ucb公司 |
4－氨基哌啶衍生物,它们的制备方法和它们作为药物的用途
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
US20040198777A1
(en)
|
2002-12-20 |
2004-10-07 |
Mitokor, Inc. |
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
|
|
JPWO2004089410A1
(ja)
|
2003-04-03 |
2006-07-06 |
協和醗酵工業株式会社 |
神経因性疼痛の予防及び／または治療剤
|
|
WO2004099164A1
(en)
|
2003-05-02 |
2004-11-18 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
WO2005012296A1
(en)
|
2003-07-28 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
|
|
CA2539276A1
(en)
|
2003-09-17 |
2005-03-31 |
Decode Genetics Ehf. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
US7932272B2
(en)
|
2003-09-30 |
2011-04-26 |
Eisai R&D Management Co., Ltd. |
Antifungal agent containing heterocyclic compound
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10356579A1
(de)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
WO2005066238A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Medicinal compositions and method for the preparation thereof
|
|
ATE437880T1
(de)
|
2004-02-04 |
2009-08-15 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
|
WO2006033795A2
(en)
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
SI1863476T1
(sl)
|
2005-03-16 |
2016-05-31 |
Meda Pharma Gmbh & Co. Kg |
Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
|
|
WO2006105304A2
(en)
|
2005-03-31 |
2006-10-05 |
Janssen Pharmaceutica N.V. |
Phenyl and pyridyl lta4h modulators
|
|
JP2008540395A
(ja)
|
2005-05-03 |
2008-11-20 |
ファイザー・インク |
アミドレソルシノール化合物
|
|
CA2610671A1
(en)
|
2005-05-31 |
2006-12-07 |
Astrazeneca Ab |
Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
BRPI0616187A2
(pt)
|
2005-09-21 |
2011-06-14 |
Decode Genetics Ehf |
composto, composiÇço farmacÊutica, e, uso de uma quantidade terapeuticamente eficaz de um composto
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007079003A2
(en)
*
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Amide inhibitors of leukotriene a4 hydrolase
|
|
EP3205644A1
(en)
|
2005-12-29 |
2017-08-16 |
Celtaxsys Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
EP2058309A4
(en)
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
BRPI0718059A2
(pt)
*
|
2006-10-19 |
2013-11-05 |
Holffmann La Roche Ag F |
Aminometil-2-imidazóis com afinidade com os receptores amina-associado traço
|
|
JP5219465B2
(ja)
*
|
2006-11-10 |
2013-06-26 |
大塚製薬株式会社 |
医薬
|
|
ES2620818T3
(es)
|
2006-12-14 |
2017-06-29 |
Janssen Pharmaceutica N.V. |
Procedimiento para la preparación de derivados de piperazinil y diazepanil benzamida
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
RU2010103104A
(ru)
|
2007-07-02 |
2011-08-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные имидазола в качестве антагонистов рецептора ccr2
|
|
CA2695331A1
(en)
|
2007-08-03 |
2009-02-12 |
F. Hoffmann-La Roche Ag |
Pyridinecarboxamide and benzamide derivatives as taar1 ligands
|
|
AR068498A1
(es)
|
2007-09-27 |
2009-11-18 |
Merck & Co Inc |
Compuestos de oxadiazol para inhibicion de biosintesis de leucotrienos
|
|
US7902181B2
(en)
|
2007-12-12 |
2011-03-08 |
Astrazeneca Ab |
Compounds 010
|
|
EA201001359A1
(ru)
|
2008-02-26 |
2011-04-29 |
Новартис Аг |
Гетероциклические соединения в качестве ингибиторов cxcr2
|
|
FR2928070A1
(fr)
|
2008-02-27 |
2009-09-04 |
Sumitomo Chemical Co |
Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
PT2268646E
(pt)
|
2008-04-11 |
2013-12-10 |
Janssen Pharmaceutica Nv |
Aminas de tiazolopiridina-2-iloxi-fenil e de tiazolopirazina-2-iloxi-fenilo como moduladores da hidrolase de leucotrieno a4
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
EP2222272B1
(en)
|
2008-08-07 |
2012-11-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
WO2010118232A1
(en)
|
2009-04-09 |
2010-10-14 |
Elan Pharma International Limited |
Controlled-release clozapine compositions
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
EP2493852B1
(en)
*
|
2009-10-30 |
2014-04-09 |
Janssen Pharmaceutica NV |
4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
|
|
AU2010328419A1
(en)
|
2009-12-07 |
2012-06-21 |
Targacept, Inc. |
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
HUE052110T2
(hu)
*
|
2010-07-29 |
2021-04-28 |
Rigel Pharmaceuticals Inc |
AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
|
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
|
AP3339A
(en)
|
2011-03-14 |
2015-07-31 |
Boehringer Ingelheim Int |
Benzodioxane inhibitors of leukotriene production
|
|
WO2012125832A2
(en)
|
2011-03-15 |
2012-09-20 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial agents
|
|
CN108014340A
(zh)
|
2011-04-12 |
2018-05-11 |
莫伊莱麦屈克斯公司 |
用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
|
|
EP2714661B1
(en)
|
2011-05-23 |
2015-09-30 |
Janssen Pharmaceutica, N.V. |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
CN103159742B
(zh)
*
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
WO2013142369A1
(en)
|
2012-03-23 |
2013-09-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of pulmonary hypertension with leukotriene inhibitors
|
|
AU2014249168B2
(en)
|
2013-03-12 |
2018-07-12 |
Celltaxis, Llc |
Methods of inhibiting leukotriene A4 hydrolase
|
|
EP2968265A4
(en)
|
2013-03-14 |
2016-12-28 |
Celtaxsys Inc |
INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
|
|
MX2015011678A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
AU2014240042C1
(en)
|
2013-03-14 |
2019-09-05 |
Celltaxis, Llc |
Inhibitors of leukotriene A4 hydrolase
|